BELX was qualified for the company roadshow at the 6th China BioMed Innovation and Investment Conference (CBIIC),
marking its first step towards international collaboration in the Asia-Pacific region.
China BioMed Innovation and Investment Conference (CBIIC) is a high-profile platform for partnering
and is praised as the most important matchmaking summit in Asia-Pacific region,
it is organized by China Pharmaceutical Innovation Promotion Association
and co-organized by China Securities Association, China Medical Device Industry Association,
Hong Kong Stock Exchange, China Hospital Association, Randy International Think Tank
and Emeda Pharmaceutical Consulting.
Copyright (c) 2020 BELX Bio-Pharmaceutical (Taiwan) Corporation. All rights reserved